This webinar will show high-throughput functional annotation of human ion channel variants associated with excitation disorders will be described along with use of the Syncropatch 384PE to measure subtype selective activation of KV7 potassium channels as well as inhibition of voltage gated sodium channels like NaV1.7, NaV1.1, and NaV1.5. Organisation: Icagen Inc.
AstraZeneca has implemented the Nanion SyncroPatch 384PE electrophysiology platform. This webinar will show how AstraZeneca and Genedata developed a processing and analysis pipeline for the complex data, reading binary raw data directly from the instrument into Genedata Screener. Organisation: Genedata AG.
This webinar gives you an overview on the SURFE²R technology and its applications. Furthermore, we invited Dr. Thomas Licher (Sanofi Germany) as speaker, to present his work and experiences on the SURFE²R 96SE device.